Document Detail

Sticking to the knitting: CIHR, innovation and Canadian biotech.
MedLine Citation:
PMID:  16078405     Owner:  NLM     Status:  MEDLINE    
The novel proposal outlined by Glenn Brimacombe suggests that the federal government directly participate in funding incremental venture capital investment in Canadian biotechnology, with the goal of facilitating commercialization of Canadian biotechnology and health sciences intellectual property. In this way, they suggest, the economic development benefits of the Canadian current investment in health sciences will be increased. The proposal is based on two premises that need further evaluation: (1) the biotechnology sector in Canada presently underperforms in terms of value creation; (2) this underperformance is due to inadequate venture capital investment. It is the author's view that, although several measures do suggest relative system underperformance, this is likely due to structural differences rather than inadequate venture capital investment. The absence of large, integrated, global biopharmaceutical firms based in Canada, the large number of very small biotech firms and the absence of a clear federal policy mandate supporting technology transfer and underinvestment in public sector funded basic research may all be contributory factors. Given the Canadian biotech sector's current efficiency at creating value from limited public investment in basic science, increasing the core CIHR budget might be an even better investment opportunity for limited incremental funding.
Jeff Edelson
Related Documents :
17971345 - Image quality evaluation and patient dose assessment of medical fluoroscopic x-ray syst...
18634625 - Public-private partnerships in the health sector: the danish experience.
15282025 - Public - private 'partnerships' in health - a global call to action.
15459165 - Health care of female outpatients in south-central india: comparing public and private ...
10628185 - Contribution of nutrition to the health transition in developing countries: a framework...
18941925 - Response to commentators of "a critique of positive responsibility".
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  Healthcare quarterly (Toronto, Ont.)     Volume:  8     ISSN:  1710-2774     ISO Abbreviation:  -     Publication Date:  2005  
Date Detail:
Created Date:  2005-08-04     Completed Date:  2005-08-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101208192     Medline TA:  Healthc Q     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  65-8     Citation Subset:  H    
Johnson & Johnson Pharmaceutical Research and Development.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biotechnology / economics*
Capital Financing
Diffusion of Innovation*
Financing, Government
Intellectual Property
National Health Programs*
Comment On:
Healthc Q. 2005;8(3):61-5, 2   [PMID:  16078404 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Health, healthcare and nation-building: a three-dimensional approach to innovation in Canada.
Next Document:  Fraser Health PACS project: learning from experience in planning.